Publications by authors named "Yuliya A Zaytseva"
Article Synopsis
- A breast cancer patient with estrogen receptor-positive cancer relapsed after two and a half years of treatment, leading to the addition of everolimus to her ongoing exemestane therapy due to the tumor's potential sensitivity to hormone treatment.
- After a brief period on oral chemotherapy failed due to her rapidly worsening health, a BRCA test showed a significant deletion in the BRCA2 gene, prompting the use of olaparib as a last-resort treatment.
- Remarkably, the patient experienced a dramatic recovery known as the "Lazarus response," with her metastatic cancer showing complete metabolic response on a PET-CT scan after just one month of olaparib therapy, highlighting the need for further studies of PARP inhibitors in patients
